You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
美单日新增21.9万宗新冠确诊破纪录 专家料未来三个月极端艰巨
阿思达克 12-04 16:19
美国新冠疫情加剧。据美国约翰霍普金斯大学统计,截至美国西岸时间午夜,即本港时间下午4时,美国累计新冠确诊14,143,801宗,单日新增218,845宗,单日新增突破20万宗,并创纪录新高。累计新冠死亡个案276,366宗,单日新增2,531宗。

《CNBC》报道,现时美国逾10万新冠病人正留院接受治疗,疫情加剧对医疗系统带来沉重压力。美国疾病管制与预防中心(CDC)主任Robert Redfield料,未来三个月属美国公共卫生历史上最艰难时期,料新增、入院及死亡个案续增。美国新冠疫苗正迈向审批最後阶段,辉瑞(PFE.US)及Moderna(MRNA.US)已向美国食品药物管理局(FDA)申请药品紧急使用授权。

以下为美国过去八日每日新冠疫情统计。

日期│累计确诊│单日新增确诊│累计死亡│单日新增死亡

12月3日(四)│14,143,801宗│+218,845宗(纪录新高)│276,366宗│+2,531宗

12月2日(三)│13,924,956宗│+199,035宗│273,835宗│+3,190宗(纪录新高)

12月1日(二)│13,725,921宗│+184,697宗│270,645宗│+2,558宗

11月30日(一)│13,541,224宗│+156,574宗│268,087宗│+1,212宗

11月29日(日)│13,384,650宗│+137,999宗│266,875宗│+812宗

11月28日(六)│13,246,651宗│+154,893宗│266,063宗│+1,204宗

11月27日(五)│13,091,758宗│+207,911宗│264,859宗│+1,404宗

11月26日(四)│12,883,847宗│+106,093宗│263,455宗│+1,189宗

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account